Health Information Center

EASD 2009: Lantus defended amid allegations of increased cancer risk

It presenters at the conference discussed the current evidence and its limitations. However, a potential mechanism by which insulin could promote cancer cell growth was also proposed. ( http://www.bharatbook.com/detail.asp?id=91847&rt=Commercial-Insight-Cardiovascular-and-Metabolic-Market-Overview-Diabetes-to-the-fore-as-generics-hit-primary-care-markets.html )

Although the European Association for the Study of Diabetes (EASD) recommended the continued use of Lantus in type 1 and type 2 diabetics, it has called for increased research into the relationship between insulin therapy – particularly Lantus (insulin glargine; Sanofi-Aventis) – and the risk of cancer.

It was postulated during the discussion at the 2009 EASD meeting that insulin use may be related to the increased incidence of cancer seen in diabetics over that seen in the general population. The preliminary data discussed in the symposium suggested lower rates of cancer with Levemir (insulin detemir; Novo Nordisk) compared to neutral protamine Hagedorn (NPH), but higher rates with Lantus. Continue reading ‘EASD 2009 – Lantus defended amid allegations of increased cancer risk’ »

The US department of energy announced massive investment the renewable industry including $60bn in clean energy investments, which will include $11bn in a smart grid system, $2bn in developing the next generation of energy storage batteries. An announced move away from corn-based ethanol fuel and $1.8bn investment in the next generation of biofuels will stimulate the vehicular fuel industry, towards a cleaner, more efficient system. The new administration has announced intention to develop available offshore renewable energy source located on the continental shelf area. The area has vast potential and scientists estimate that 900GW of wind power may be achieved.

Although still primarily a conventional thermal based country, through incentivized support in renewable energy, a new energy market is beginning to evolve. Recent addition has been made to the energy mix by way of renewable energy technologies which include power from the wind – wind turbines, and power from the sun – solar cells, and geothermal – relying on the heat that can be found at varying degrees of depth into the Earth’s surface. In the last decade newly installed renewable energy technologies are starting to gain a notable share of the market. This report documents the growth of this new market, showing its current status and projecting where it is likely to grow to in the foreseeable future. This document gathers the statistical data on the different types of energy generation, combines and contrasts them against each other to show the clear leaders, drivers to change and future growth. Continue reading ‘The Diabetes Market Outlook To 2014: Market Dynamics, Competitive Landscape, Emerging Therapies-Aarkstore Enterprise’ »

Global healthcare market is evolving from traditional healthcare system to modern healthcare system of E-health which minimizes the physical movement of patients and enhances the coverage of healthcare services. As the world population is aging, it has resulted in increase of global healthcare expenditure. The major increase in healthcare expenditure is being witnessed in developed nations where population is ageing at a higher pace compared to less developed nations. Aging population has resulted in increase in demand of healthcare services which is already in an over-pressurized state.

It is now believed that telemedicine is going to be an important component of the modern healthcare system which will ease the pressure over the existing healthcare system which is suffering from problems like lack of required number of physicians, high cost and limited reach in the rural areas. Telemedicine, being a component of E-health, is a provision of healthcare services that uses telecommunication technology and multimedia equipment to provide healthcare solutions over a geographic distance. Continue reading ‘New Report "analysis Of Telemedicine Market" Available Through Aarkstore Enterprise’ »

Axcan Pharma Inc.-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.

Scope of the reports

Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company’s management team and its products. . Continue reading ‘Axcan Pharma Inc.-Company Report’ »

New England Journal of Medicine recently published a study affirming Fosamax’s tendency to cause sudden, low-energy femur fracture to long-time users of the biphosphonate drug, a revelation affecting many osteoporosis patients which concerns the doctors treating them. The medical world was divided relating to the Fosamax study recently published. While there were physicians who were undeterred by the said Fosamax study, there were other doctors who were not happy with the issue. Dr. Kenneth Egol, an orthopedic surgery professor hailing from New York University, examined radiographic results of patients claiming they got the fracture injury due to Fosamax drug use.

Fosamax are presently not prescribed by medical practitioners who has been assessed to having low body mass indexes, history of falls, and is known to have smoking and drinking habits in light of the rising claims against Fosamax’s adverse effects. “If a person is diagnosed with osteoporosis and it’s decided they should be treated with bisphosphonates, they should try the medications.” shared by Dr. Ken Lyles of Duke University on his thoughts in light of the study recently published.

Continue reading ‘Opposing Thoughts by Physicians About Fosamax Femur Fracture Research’ »

Cancer Head and Neck Cancer Therapy Area Pipeline Report

This report contains detailed information on the head and neck cancer drug pipeline. This report provides insight into the pipeline status of head and neck cancer drugs by company and by stage as well as a summary of the latest news and developments in this area. ( http://www.bharatbook.com/detail.asp?id=126756&rt=Cancer-Head-and-Neck-Cancer-Therapy-Area-Pipeline-Report.html )

Scope of the report:

Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area. Continue reading ‘Cancer Head And Neck Cancer Therapy Area Pipeline Report’ »

Alliance Pharma plc-Company Report

Bharatbook.com added a new report on “Alliance Pharma plc-Company Report” into its market report catalogue for reselling.

Alliance Pharma plc-Company Report provides up to date insight into the structure and operations of privately-held pharmaceutical, biotechnology and biomedical companies.

Scope of the reports

Accessing accurate, current and comprehensive content on private companies can be challenging and Life Science Analytics has created a suite of reports that deliver the latest information on over 1,000 private firms. Each report provides a corporate overview and business description along with detail on the company’s management team and its products. . Continue reading ‘Alliance Pharma plc-Company Report’ »

Preclinical Models: Innovative solutions to accelerate drug discovery and development

Preclinical models are developed to test lead compounds for toxicity and efficacy. They are valuable tools to minimize development costs and reduce failures prior to commencement of human trials. Problems with traditional animal models such as cost, ethics, and suitability has prompted researchers to develop new models and systems to overcome such disadvantages. Continue reading ‘Preclinical Models – Innovative Solutions To Accelerate Drug Discovery And Development’ »

Oncothyreon, Inc.-Therapeutic Competitors includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with indication and stage of development, and competitors by therapeutic indication. The report also includes recent company news updates.

Competitor Reports provide detailed analysis of a company’s products by therapeutic indication, a summary of its overall pipeline as well as insight into the predicted likelihood of clinical success for each pipeline product. Every Competitor Report compares the company against its primary competitors by individual therapeutic indication. Continue reading ‘Oncothyreon, Inc.-Therapeutic Competitors’ »

Opticians & Optical Goods – Market Assessment

This Market Assessment report provides an analysis of the opticians and optical goods market, which includes spectacles, contact lenses and solutions, laser eye treatment, sight tests and general ophthalmic services. It updates a previous Opticians & Optical Goods Market Assessment report published in August 2008. ( http://www.bharatbook.com/detail.asp?id=83563&rt=Opticians-Optical-Goods-Market-Assessment.html )

The market suffered the impacts of the recession in 2009 and several sectors experienced falling revenues. The downturn was the first reversal in an upward sales trend that had lasted for some years. Expenditure by opticians and suppliers of optical goods in areas such as main media advertising also declined in 2009, compared with 2008, and this was probably due in part to the recession. However, a growing population — in particular, the number of adults aged 60 and over — meant that the number of NHS sight tests taken in the year to March 2009 increased over the corresponding period of 2007/2008 and helped to sustain income from this source of revenue. Continue reading ‘Opticians & Optical Goods – Market Assessment’ »